Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

ClinicalTrials.gov ID: NCT05192200

Public ClinicalTrials.gov record NCT05192200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN OPEN LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE SAFETY OF PF-06823859 ADMINISTERED TO ADULT PARTICIPANTS ≥18 AND ≤80 WITH ACTIVE DERMATOMYOSITIS.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.

Study identification

NCT ID
NCT05192200
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
24 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2021 (Actual)
Primary completion
Nov 20, 2023 (Actual)
Completion
Nov 20, 2023 (Actual)
Last update posted
Feb 6, 2025

2021 – 2023

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
University of Alabama at Birmingham, Department of Dermatology Birmingham Alabama 35294 —
Mayo Clinic Scottsdale Arizona 85259 —
Attune Health Research Inc. Beverly Hills California 90211 —
Mayo Clinic in Florida Jacksonville Florida 32224 —
KU Clinical Research Center - Clinical and Translational Science Unit (CTSU) Fairway Kansas 66205 —
KU Clinical and Translational Science Unit (CTSU) Rainbow Kansas City Kansas 66160 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
Brigham and Women's Hospital - CTH Boston Massachusetts 02115 —
Center for Outpatient Health St Louis Missouri 63108 —
Washington University School of Medicine St Louis Missouri 63108 —
Washington University School of Medicine St Louis Missouri 63110 —
NYU Grossman School of Medicine, The Ronald O. Perelman Department of Dermatology New York New York 10016 —
NYU Langone Health Clinical Research Center New York New York 10016 —
NYU Langone Radiology - Ambulatory Care Center East 41st Street New York New York 10017 —
Mount Sinai Doctors Dermatology New York New York 10028 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Center for Human Phenomic Science Philadelphia Pennsylvania 19104 —
University of Pennsylvania, Perelman Center for Advanced Medicine (PCAM) Philadelphia Pennsylvania 19104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05192200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2025 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05192200 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →